跳至主要内容
临床试验/NCT06982560
NCT06982560已完成不适用

Assessment and Management of Acute Heart Failure Patients Guided by Electrical Cardiometry

Alexandria University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2023年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
mortality and intensive care unit (ICU) length of stay

研究概览

简要总结

The goal of this clinical trial is to assess if electrical cardiometry (EC) could help in managing acute heart failure (AHF). The main questions it aims to answer are:

  1. Is there effect of use of cardiometry on rate of use of vasopressors, vasodilators and inotropes?
  2. is there effect of use of cardiometry on mortality and hospital length of stay?

Researchers compared cardiometry to traditional methods like clinical examination, lung ultrasound and inferior vena cava.

Participants were divided into two groups, one managed by cardiometry and the other by traditional methods, then followed till improvement or death and compared regarding use of medications, length of stay and mortality

详细描述

The purpose of the research is to assess the role of electrical cardiometry in hemodynamic monitoring in studied cases with acute heart failure to guide treatment.

This is a prospective controlled research that involved fifty patients, diagnosed with acute heart failure and admitted to critical care units at Alexandria University Hospitals, patients were divided into 2 groups:

Group A: was assessed by traditional methods which include: clinical examination including chest auscultation and systolic blood pressure measurement, lung ultrasound and inferior vena cava assessment and managed according to the results of these parameters.

Group B: was assessed by electrical cardiometry parameters as cardiac output, thoracic fluid content (TFC) and systemic vascular resistance (SVR) and was managed as following: inotropes up and down titration according to cardiac output readings, use of vasopressors or vasodilators according to SVR readings, doses of diuretics were modified according to TFC readings.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •acute heart failure

排除标准

  • •pregnant females, atrial fibrillation, severe valvular diseases, skin lesions in thoracic area, large pleural effusion

研究组 & 干预措施

Group A: traditional group

Placebo Comparator

traditional methods like clinical examination, lung ultrasound, inferior vena cava

干预措施: traditonal methods (Other)

Group B: cardiometry group

Experimental

use of cardiometry parameters like cardiac output, thoracic fluid content and systemic vascular resistance

干预措施: electrical cardiometry (Device)

结局指标

主要结局

mortality and intensive care unit (ICU) length of stay

时间窗: 7 days

number of days in ICU and mortality in ICU

次要结局

  • use of vasopressors, vasodilators, inotropes(7 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验